The UK government has unveiled significant details regarding the upcoming judge-led public inquiry into the devastating Nottingham attacks that claimed the lives of three men – Ian Coates, Barnaby Webber, and Grace O’Malley-Kumar – on June 13, 2023. The horrific incident, in which all three were fatally stabbed by Valdo Calocane, has sparked widespread grief within the community and intense scrutiny of law enforcement procedures.
The inquiry, to be chaired by Her Honour Judge Deborah Taylor, will conduct a comprehensive investigation into every aspect of the case, from the initial response to the crime scene to the subsequent handling of Mr. Calocane’s mental health diagnosis and treatment. A key focus will be on assessing whether police procedures adequately addressed the escalating risk posed by the perpetrator. The inquiry has been granted statutory powers, including the ability to compel witnesses to provide testimony under oath, ensuring a thorough examination of all relevant evidence. Justice Secretary Shabana Mahmood announced that the full terms of reference for the inquiry would be made available in both Houses of Parliament “at the earliest opportunity,” allowing for public scrutiny and engagement.
Valdo Calocane was sentenced to a hospital order in January 2024 after pleading guilty to three counts of manslaughter on the grounds of diminished responsibility, alongside three charges of attempted murder. He had previously been diagnosed with paranoid schizophrenia prior to the attacks. Following his sentencing, Emma Webber, mother of victim Barnaby Webber, expressed her deep dissatisfaction, stating that “true justice has not been served.” The family’s sentiment reflects a broader concern among the victims’ families regarding the adequacy of the response and the subsequent handling of the case. The public inquiry is expected to delve into questions surrounding Calocane’s mental health care, highlighting potential gaps in services and contributing to ongoing discussions about access to psychiatric support for individuals with serious mental illnesses.
The investigation will also examine whether sufficient preventative measures were taken, considering Calocane’s documented history of paranoid schizophrenia. The inquiry’s findings are anticipated to inform future policies and procedures related to public safety and the management of high-risk individuals.
